Hesperos, Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip multi-organ, microphysiological system. This breakthrough technology enables unprecedented preclinical insight into disease states and whether a novel compound will be safe and effective for treatment in humans - something that previously required costly animal testing and human trials to determine.

The Human-on-a-Chip is a reconfigurable, multi-organ in vitro platform that reproduces the functional aspects of human physiology enabling evaluation of the efficacy and off-target toxicity of parent compounds and their metabolites for both single drug treatments and drug-drug combinations.

Operating as a CRO, Hesperos offers compound safety and efficacy testing services using the Human-on-a-Chip platform.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2015
Main Therapeutic Focus:
Lead Product in Development:
Human-on-a-Chip
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Scientist
Hesperos, Inc.